Van den Elsen P - Search Results

1

Analysis of MHC class II transcription in two type III bare lymphocyte syndrome patients of a single family.

Lambert M, Van Eggermond M, Verheij C, Van Ree J, Van den Elsen P. Lambert M, et al. Among authors: van eggermond m, van ree j, van den elsen p. Immunodeficiency. 1993;4(1-4):277-84. Immunodeficiency. 1993. PMID: 8167718 No abstract available.

2

TCR V alpha- and V beta-gene segment use in T-cell subcultures derived from a type-III bare lymphocyte syndrome patient deficient in MHC class-II expression.

Lambert M, Van Eggermond M, Mascart F, Dupont E, Van den Elsen P. Lambert M, et al. Among authors: van eggermond m, van den elsen p. Dev Immunol. 1992;2(3):227-36. doi: 10.1155/1992/29814. Dev Immunol. 1992. PMID: 1320968 Free PMC article.

3

Analysis of the peripheral T-cell compartment in the MHC class II deficiency syndrome.

Lambert M, van Eggermond M, Andrien M, Mascart F, Vamos E, Dupont E, van den Elsen P. Lambert M, et al. Among authors: van eggermond m, van den elsen p. Res Immunol. 1991 Nov-Dec;142(9):789-98. doi: 10.1016/0923-2494(91)90124-2. Res Immunol. 1991. PMID: 1796210

4

Lymphokine gene transcription in CD4+CD8- T cells of a type III bare lymphocyte syndrome patient.

Lambert M, van Eggermond M, van den Elsen P. Lambert M, et al. Among authors: van eggermond m, van den elsen p. Hum Immunol. 1993 Jul;37(3):143-8. doi: 10.1016/0198-8859(93)90179-5. Hum Immunol. 1993. PMID: 8244777

5

T-cell repertoire development in MHC class II deficient humans.

van Eggermond M, Lambert M, Mascart F, Dupont E, van den Elsen P. van Eggermond M, et al. Among authors: van den elsen p. Adv Exp Med Biol. 1993;329:135-40. doi: 10.1007/978-1-4615-2930-9_23. Adv Exp Med Biol. 1993. PMID: 8397472 No abstract available.

6

The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine.

Lambert M, van Eggermond MC, Kraakman ME, Schuurman RK, van den Elsen PJ. Lambert M, et al. Among authors: van den elsen pj, van eggermond mc. Res Immunol. 1990 Feb;141(2):129-40. doi: 10.1016/0923-2494(90)90132-i. Res Immunol. 1990. PMID: 1697090

7

Epigenetic silencing of MHC2TA transcription in cancer.

Holling TM, van Eggermond MC, Jager MJ, van den Elsen PJ. Holling TM, et al. Biochem Pharmacol. 2006 Nov 30;72(11):1570-6. doi: 10.1016/j.bcp.2006.06.034. Epub 2006 Aug 1. Biochem Pharmacol. 2006. PMID: 16879803 Review.

8

Transcriptional silencing of RFXAP in MHC class II-deficiency.

van Eggermond MC, Tezcan I, Heemskerk MH, van den Elsen PJ. van Eggermond MC, et al. Mol Immunol. 2008 May;45(10):2920-8. doi: 10.1016/j.molimm.2008.01.026. Epub 2008 Mar 12. Mol Immunol. 2008. PMID: 18336911

9

T cell development in a major histocompatibility complex class II-deficient patient.

van Eggermond MC, Rijkers GT, Kuis W, Zegers BJ, van den Elsen PJ. van Eggermond MC, et al. Among authors: van den elsen pj. Eur J Immunol. 1993 Oct;23(10):2585-91. doi: 10.1002/eji.1830231031. Eur J Immunol. 1993. PMID: 8405058

10

Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.

Peijnenburg A, Gobin SJ, van Eggermond MC, Godthelp BC, van Graafeiland N, van den Elsen PJ. Peijnenburg A, et al. Among authors: van den elsen pj, van graafeiland n, van eggermond mc. J Immunol. 1997 Sep 15;159(6):2720-7. J Immunol. 1997. PMID: 9300692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page